Bioteknologiens Gjennombrudd og Nye Grenser
Kilder
- STAT: STAT+: Celcuity’s breast cancer drug approved, its first
- Finance: Celcuity shares fall as delayed breast cancer drug launch eclipses first US FDA approval - Yahoo Finance
- BioSpace: Celcuity wins breast cancer nod, securing ‘differentiated foothold’ in market - BioSpace
- BioPharma Dive: Braveheart, Attovia join next wave of biotech IPOs
- GEN: Modular Modeling Drives Smarter mRNA Manufacturing
- GEN: Ketogenic Diet Shows Opposite Effects on Cancer Risk in Mouse Small Intestine and Colon - Genetic Engineering and Biotechnology News
- STAT: STAT+: A new biotech startup tries to tackle obesity, but not in the way you might expect
- STAT: Celcuity’s breast cancer drug approved, its first - STAT
- STAT: What to know about the parasitic diarrhea outbreak - STAT
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.